Search by Drug Name or NDC
NDC 70518-2781-00 Epinephrine 0.1 mg/mL Details
Epinephrine 0.1 mg/mL
Epinephrine is a INTRACARDIAC; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by REMEDYREPACK INC.. The primary component is EPINEPHRINE.
MedlinePlus Drug Summary
Epinephrine injection is used along with emergency medical treatment to treat life-threatening allergic reactions caused by insect bites or stings, foods, medications, latex, and other causes. Epinephrine is in a class of medications called alpha- and beta-adrenergic agonists (sympathomimetic agents). It works by relaxing the muscles in the airways and tightening the blood vessels.
Related Packages: 70518-2781-00Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Epinephrine Injection
Product Information
NDC | 70518-2781 |
---|---|
Product ID | 70518-2781_04b4a7f6-0eee-3320-e063-6394a90aea51 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Epinephrine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Epinephrine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRACARDIAC; INTRAVENOUS |
Active Ingredient Strength | 0.1 |
Active Ingredient Units | mg/mL |
Substance Name | EPINEPHRINE |
Labeler Name | REMEDYREPACK INC. |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | UNAPPROVED DRUG OTHER |
Application Number | n/a |
Listing Certified Through | 2024-12-31 |
Package
NDC 70518-2781-00 (70518278100)
NDC Package Code | 70518-2781-0 |
---|---|
Billing NDC | 70518278100 |
Package | 10 VIAL in 1 PACKAGE (70518-2781-0) / 10 mL in 1 VIAL |
Marketing Start Date | 2020-06-11 |
NDC Exclude Flag | N |
Pricing Information | N/A |